Neuflex
Payments companies reported to CMS as associated with Neuflex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuflex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuflex
These are the largest totals companies reported as associated with Neuflex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Dipasco | Saint Louis, MO | Surgical Oncology | $48,787.45 |
| David Dibardino | Philadelphia, PA | Critical Care Medicine (Internal Medicine) | $17,940.77 |
| Eren Berber | Cleveland, OH | Surgery | $10,026.00 |
| Eric Jensen | Minneapolis, MN | Surgical Oncology | $6,380.00 |
| David Iannitti | Charlotte, NC | Surgery | $5,400.00 |
| Robert Short | Pittsburgh, PA | Diagnostic Radiology | $675.00 |
| Khashayar Farsad | Portland, OR | Vascular & Interventional Radiology | $600.00 |
| Steven Curley | Tyler, TX | Surgical Oncology | $505.00 |
| Steven Trocha | Greenville, SC | Surgical Oncology | $460.00 |
| Monica Roca | Orlando, FL | Vascular & Interventional Radiology | $450.00 |
Prescribed Neuflex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.